NCT03151226 is a NA clinical trial of Capnography monitoring in Respiratory Depression, sponsored by Wake Forest University Health Sciences.

Who is sponsoring NCT03151226?

NCT03151226 is sponsored by Wake Forest University Health Sciences.

What drugs are being tested in NCT03151226?

Interventions in NCT03151226: Capnography monitoring.

What condition does NCT03151226 study?

NCT03151226 studies Respiratory Depression.

Is NCT03151226 still recruiting?

NCT03151226 is currently terminated. Last updated 7 September 2018.

Are results published for NCT03151226?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-09-07 · How we verify

NCT03151226

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OSA Screen Negative With Spinal Duramorph

Terminated NA Results posted Last updated 7 September 2018

What this trial tests

NA trial testing Capnography monitoring in Respiratory Depression in 3 participants. Terminated before completion.

Timeline

3 August 2015

Primary endpoint
1 October 2015

1 October 2015

Quick facts

Lead sponsor	Wake Forest University Health Sciences
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	3
Start date	3 August 2015
Primary completion	1 October 2015
Estimated completion	1 October 2015
Sites	1 location across United States

Drugs / interventions tested

Capnography monitoring

Conditions studied

Respiratory Depression — all drugs for Respiratory Depression →

Sponsor

Wake Forest University Health Sciences

Who can join

Adults 18 to 50, female only, with Respiratory Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non emergent scheduled cesarean sections will be consented to participate in this study of patients who have screened negative for obstructive sleep apnea and who are also BMI\>/= 35 to have capnography monitoring postoperatively. The capnography and pulse oximetry will be initiated in the post anesthesia care unit and be worn for 12-24 hours after delivery. Data will be retrieved after that time period in a deidentified fashion. Medication usage will be reviewed as well as the standard of care information from the duramorph monitoring will be retrieved.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Capnography monitoring

Trials testing the same drug.

NCT05030870 — Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients · NA · completed

Other recruiting trials for Respiratory Depression

Currently open trials in the same condition.

NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
NCT06967259 — ENA-001 for Opioid Induced Respiratory Depression · Phase 1 · active not recruiting
NCT06823661 — Transcutaneous Electrical Stimulation for Apnea Detected by Capnography · NA · recruiting
NCT06777758 — Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments · Phase 4 · recruiting
NCT06772961 — Effect of Percutaneous Electrical Acupoint Stimulation on the Improvement of Incidence of Adverse Respiratory Events · NA · recruiting

Other Wake Forest University Health Sciences trials

Trials by the same sponsor.

NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial · NA · not yet recruiting
NCT06876896 — Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter · NA · recruiting
NCT07227051 — Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity · NA · recruiting
NCT07215624 — Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03151226 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wake Forest University Health Sciences
Last refreshed: 7 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03151226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing